Cargando…
Novel COVID-19 therapies: the road ahead for rheumatology
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797007/ https://www.ncbi.nlm.nih.gov/pubmed/35128471 http://dx.doi.org/10.1016/S2665-9913(22)00007-8 |
| _version_ | 1784641444480286720 |
|---|---|
| author | The Lancet Rheumatology |
| author_facet | The Lancet Rheumatology |
| author_sort | The Lancet Rheumatology |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8797007 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87970072022-01-31 Novel COVID-19 therapies: the road ahead for rheumatology The Lancet Rheumatology Lancet Rheumatol Editorial Elsevier Ltd. 2022-02 2022-01-28 /pmc/articles/PMC8797007/ /pubmed/35128471 http://dx.doi.org/10.1016/S2665-9913(22)00007-8 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial The Lancet Rheumatology Novel COVID-19 therapies: the road ahead for rheumatology |
| title | Novel COVID-19 therapies: the road ahead for rheumatology |
| title_full | Novel COVID-19 therapies: the road ahead for rheumatology |
| title_fullStr | Novel COVID-19 therapies: the road ahead for rheumatology |
| title_full_unstemmed | Novel COVID-19 therapies: the road ahead for rheumatology |
| title_short | Novel COVID-19 therapies: the road ahead for rheumatology |
| title_sort | novel covid-19 therapies: the road ahead for rheumatology |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797007/ https://www.ncbi.nlm.nih.gov/pubmed/35128471 http://dx.doi.org/10.1016/S2665-9913(22)00007-8 |
| work_keys_str_mv | AT thelancetrheumatology novelcovid19therapiestheroadaheadforrheumatology |